Literature DB >> 19924712

Multistage analysis strategies for genome-wide association studies: summary of group 3 contributions to Genetic Analysis Workshop 16.

Rosalind J Neuman1, Yun Ju Sung.   

Abstract

This contribution summarizes the work done by six independent teams of investigators to identify the genetic and non-genetic variants that work together or independently to predispose to disease. The theme addressed in these studies is multistage strategies in the context of genome-wide association studies (GWAS). The work performed comes from Group 3 of the Genetic Analysis Workshop 16 held in St. Louis, Missouri in September 2008. These six studies represent a diversity of multistage methods of which five are applied to the North American Rheumatoid Arthritis Consortium rheumatoid arthritis case-control data, and one method is applied to the low-density lipoprotein phenotype in the Framingham Heart Study simulated data. In the first stage of analyses, the majority of studies used a variety of screening techniques to reduce the noise of single-nucleotide polymorphisms purportedly not involved in the phenotype of interest. Three studies analyzed the data using penalized regression models, either LASSO or the elastic net. The main result was a reconfirmation of the involvement of variants in the HLA region on chromosome 6 with rheumatoid arthritis. The hope is that the intense computational methods highlighted in this group of papers will become useful tools in future GWAS. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19924712      PMCID: PMC2996886          DOI: 10.1002/gepi.20467

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  19 in total

1.  Genomic control for association studies.

Authors:  B Devlin; K Roeder
Journal:  Biometrics       Date:  1999-12       Impact factor: 2.571

2.  Two-Stage sampling designs for gene association studies.

Authors:  Duncan Thomas; Rongrong Xie; Mulugeta Gebregziabher
Journal:  Genet Epidemiol       Date:  2004-12       Impact factor: 2.135

3.  Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies.

Authors:  Andrew D Skol; Laura J Scott; Gonçalo R Abecasis; Michael Boehnke
Journal:  Nat Genet       Date:  2006-01-15       Impact factor: 38.330

4.  Testing untyped alleles (TUNA)-applications to genome-wide association studies.

Authors:  Dan L Nicolae
Journal:  Genet Epidemiol       Date:  2006-12       Impact factor: 2.135

Review 5.  Beyond odds ratios--communicating disease risk based on genetic profiles.

Authors:  Peter Kraft; Sholom Wacholder; Marilyn C Cornelis; Frank B Hu; Richard B Hayes; Gilles Thomas; Robert Hoover; David J Hunter; Stephen Chanock
Journal:  Nat Rev Genet       Date:  2009-04       Impact factor: 53.242

6.  A new association test to test multiple-marker association.

Authors:  Xuexia Wang; Shuanglin Zhang; Qiuying Sha
Journal:  Genet Epidemiol       Date:  2009-02       Impact factor: 2.135

7.  Two-stage designs for gene-disease association studies with sample size constraints.

Authors:  Jaya M Satagopan; E S Venkatraman; Colin B Begg
Journal:  Biometrics       Date:  2004-09       Impact factor: 2.571

8.  Imputation-based analysis of association studies: candidate regions and quantitative traits.

Authors:  Bertrand Servin; Matthew Stephens
Journal:  PLoS Genet       Date:  2007-05-30       Impact factor: 5.917

9.  Two-stage joint selection method to identify candidate markers from genome-wide association studies.

Authors:  Zheyang Wu; Chatchawit Aporntewan; David H Ballard; Ji Young Lee; Joon Sang Lee; Hongyu Zhao
Journal:  BMC Proc       Date:  2009-12-15

10.  Application of imputation methods to the analysis of rheumatoid arthritis data in genome-wide association studies.

Authors:  Douglas K Childers; Guolian Kang; Nianjun Liu; Guimin Gao; Kui Zhang
Journal:  BMC Proc       Date:  2009-12-15
View more
  2 in total

1.  Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease.

Authors:  Chuong B Do; Joyce Y Tung; Elizabeth Dorfman; Amy K Kiefer; Emily M Drabant; Uta Francke; Joanna L Mountain; Samuel M Goldman; Caroline M Tanner; J William Langston; Anne Wojcicki; Nicholas Eriksson
Journal:  PLoS Genet       Date:  2011-06-23       Impact factor: 5.917

2.  Identifying Prognostic SNPs in Clinical Cohorts: Complementing Univariate Analyses by Resampling and Multivariable Modeling.

Authors:  Stefanie Hieke; Axel Benner; Richard F Schlenk; Martin Schumacher; Lars Bullinger; Harald Binder
Journal:  PLoS One       Date:  2016-05-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.